Regencell Bioscience Ownership 2024 | Who Owns Regencell Bioscience Now?


OverviewFinancialsChart

Institutional Ownership

0.01%

Insider Ownership

88.76%

Retail Ownership

11.23%

Institutional Holders

3.00

Regencell Bioscience Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.01%-1,400-14,653-91.28%6,300Mar 31, 2024
BLACKROCK INC.0.00%-238--1,071Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-13--64Mar 31, 2024

Regencell Bioscience's largest institutional shareholder is UBS GROUP AG, holding 0.01% of the company's total share outstanding, currently valued at $6.30K. The top 10 institutional shareholders own together 0.01% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.01%-1,400-14,653-91.28%6,300Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-13--64Mar 31, 2024
BLACKROCK INC.0.00%-238--1,071Mar 31, 2024

The largest Regencell Bioscience shareholder by % of total assets is UBS GROUP AG. The company owns 1.40K shares of Regencell Bioscience (RGC), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.0.00%-238--1,071Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-13--64Mar 31, 2024
UBS GROUP AG0.01%-1,400-14,653-91.28%6,300Mar 31, 2024

As of Mar 31 2024, Regencell Bioscience's largest institutional buyer is BLACKROCK INC.. The company purchased 0.00 stocks of RGC, valued at $1.07K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.01%-1,400-14,653-91.28%6,300Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-13--64Mar 31, 2024
BLACKROCK INC.0.00%-238--1,071Mar 31, 2024

As of Mar 31 2024, Regencell Bioscience's biggest institutional seller is UBS GROUP AG. The company sold -14.65K shares of RGC, valued at $6.30K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Regencell Bioscience Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Gabelli Gold Fund, Inc.4.75%3,650,000--Dec 29, 2023
AMERICAN CENTURY ETF TRUST0.00%100--Feb 29, 2024

Regencell Bioscience's largest mutual fund holder by % of total assets is "Gabelli Gold Fund, Inc.", owning 3.65M shares, compromising 4.75% of its total assets.

Regencell Bioscience Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 243-
31 Dec, 233-25.00%
30 Sep, 234100.00%
30 Jun, 232-50.00%
31 Mar, 23433.33%
31 Dec, 223-40.00%
30 Sep, 225-
30 Jun, 22525.00%
31 Mar, 224100.00%
31 Dec, 212-33.33%
30 Sep, 213-

As of 31 Mar 24, 3 institutions are holding Regencell Bioscience's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 241,651-89.87%
31 Dec, 2316,3042362.84%
30 Sep, 2366222.82%
30 Jun, 23539-26.77%
31 Mar, 23736-38.05%
31 Dec, 221,188-85.51%
30 Sep, 228,201-3.56%
30 Jun, 228,504-57.99%
31 Mar, 2220,245188.88%
31 Dec, 217,008-49.85%
30 Sep, 2113,973-

Regencell Bioscience (RGC) has 1.65K shares outstanding as of 31 Mar 24, down -89.87% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 240.01%80.85%
31 Dec, 230.13%460128.85%
30 Sep, 230.01%28562.79%
30 Jun, 230.00%12625.86%
31 Mar, 230.01%6590.43%
31 Dec, 220.01%223.27%
30 Sep, 220.06%1432.99%
30 Jun, 220.07%262.40%
31 Mar, 220.16%5214.44%
31 Dec, 210.06%453.85%
30 Sep, 210.11%-

As of 31 Mar 24, Regencell Bioscience is held by 0.01% institutional shareholders, representing a 80.85% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 24--100.00%
31 Dec, 231-66.67%
30 Sep, 233200.00%
30 Jun, 231-50.00%
31 Mar, 232-
31 Dec, 222100.00%
30 Sep, 221-80.00%
30 Jun, 22525.00%
31 Mar, 224100.00%
31 Dec, 212-33.33%
30 Sep, 213-

- institutional shareholders have increased their position in RGC stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 241-
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--100.00%
31 Mar, 231-
31 Dec, 22--100.00%
30 Sep, 222-
30 Jun, 22--
31 Mar, 22--
31 Dec, 21--
30 Sep, 21--

1 institutional shareholders have reduced their position in RGC stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 243-1,651-89.87%0.01%80.85%--100.00%1-
31 Dec, 233-25.00%16,3042362.84%0.13%460128.85%1-66.67%--
30 Sep, 234100.00%66222.82%0.01%28562.79%3200.00%--
30 Jun, 232-50.00%539-26.77%0.00%12625.86%1-50.00%--100.00%
31 Mar, 23433.33%736-38.05%0.01%6590.43%2-1-
31 Dec, 223-40.00%1,188-85.51%0.01%223.27%2100.00%--100.00%
30 Sep, 225-8,201-3.56%0.06%1432.99%1-80.00%2-
30 Jun, 22525.00%8,504-57.99%0.07%262.40%525.00%--
31 Mar, 224100.00%20,245188.88%0.16%5214.44%4100.00%--
31 Dec, 212-33.33%7,008-49.85%0.06%453.85%2-33.33%--
30 Sep, 213-13,973-0.11%-3---

Regencell Bioscience Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 28, 2018ANSCHUTZ PHILIP F10 percent owner-D-ReturnSell12,440,000$23.00$286.12M-
Feb 28, 2018ANSCHUTZ PHILIP F10 percent owner-D-ReturnSell23,708,639$23.00$545.30M-
Feb 28, 2018CAMPBELL MICHAEL Ldirector-D-ReturnSell703,660$23.00$16.18M-
Feb 28, 2018YEMENIDJIAN ALEXdirector-D-ReturnSell21,880$23.00$503.24K-
Feb 28, 2018TYRRELL JACKdirector-D-ReturnSell136,684$23.00$3.14M-
Feb 28, 2018THOMAS LEE Mdirector-D-ReturnSell46,585$23.00$1.07M-
Feb 28, 2018KEYTE DAVID Hdirector-D-ReturnSell5,767$23.00$132.64K-
Feb 28, 2018KAPLAN STEPHEN Adirector-D-ReturnSell161,033$23.00$3.70M-
Feb 28, 2018Brymer Charles Edirector-D-ReturnSell75,777$23.00$1.74M-
Feb 28, 2018BELL THOMAS D JRdirector-D-ReturnSell132,400$23.00$3.05M-
Feb 28, 2018BRANDOW PETER Bofficer EVP, General Counsel, Sec.D-ReturnSell236,515$23.00$5.44M-
Feb 28, 2018Ownby Davidofficer EVP, CFO and TreasurerD-ReturnSell256,761$23.00$5.91M-
Feb 28, 2018DUNN GREGORY Wofficer President and COOD-ReturnSell98,400$23.00$2.26M-
Feb 28, 2018MILES AMY Edirector, officer Chief Executive OfficerD-ReturnSell740,753$23.00$17.04M-
Jan 30, 2018BRANDOW PETER Bofficer EVP, General Counsel, Sec.F-InKindSell1,283$22.95$29.44K219,217
Jan 30, 2018Ownby Davidofficer EVP, CFO and TreasurerF-InKindSell1,440$22.95$33.05K237,345
Jan 30, 2018DUNN GREGORY Wofficer President and COOF-InKindSell1,738$22.95$39.89K74,971

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 28, 2018ANSCHUTZ PHILIP F10 percent owner-D-ReturnSell12,440,000$23.00$286.12M-
Feb 28, 2018ANSCHUTZ PHILIP F10 percent owner-D-ReturnSell23,708,639$23.00$545.30M-
Feb 28, 2018CAMPBELL MICHAEL Ldirector-D-ReturnSell703,660$23.00$16.18M-
Feb 28, 2018YEMENIDJIAN ALEXdirector-D-ReturnSell21,880$23.00$503.24K-
Feb 28, 2018TYRRELL JACKdirector-D-ReturnSell136,684$23.00$3.14M-
Feb 28, 2018THOMAS LEE Mdirector-D-ReturnSell46,585$23.00$1.07M-
Feb 28, 2018KEYTE DAVID Hdirector-D-ReturnSell5,767$23.00$132.64K-
Feb 28, 2018KAPLAN STEPHEN Adirector-D-ReturnSell161,033$23.00$3.70M-
Feb 28, 2018Brymer Charles Edirector-D-ReturnSell75,777$23.00$1.74M-
Feb 28, 2018BELL THOMAS D JRdirector-D-ReturnSell132,400$23.00$3.05M-
Feb 28, 2018BRANDOW PETER Bofficer EVP, General Counsel, Sec.D-ReturnSell236,515$23.00$5.44M-
Feb 28, 2018Ownby Davidofficer EVP, CFO and TreasurerD-ReturnSell256,761$23.00$5.91M-
Feb 28, 2018DUNN GREGORY Wofficer President and COOD-ReturnSell98,400$23.00$2.26M-
Feb 28, 2018MILES AMY Edirector, officer Chief Executive OfficerD-ReturnSell740,753$23.00$17.04M-
Jan 30, 2018BRANDOW PETER Bofficer EVP, General Counsel, Sec.A-AwardBuy17,298--236,515
Jan 30, 2018BRANDOW PETER Bofficer EVP, General Counsel, Sec.F-InKindSell1,283$22.95$29.44K219,217
Jan 30, 2018Ownby Davidofficer EVP, CFO and TreasurerA-AwardBuy19,416--256,761
Jan 30, 2018Ownby Davidofficer EVP, CFO and TreasurerF-InKindSell1,440$22.95$33.05K237,345
Jan 30, 2018DUNN GREGORY Wofficer President and COOA-AwardBuy23,429--98,400
Jan 30, 2018DUNN GREGORY Wofficer President and COOF-InKindSell1,738$22.95$39.89K74,971

The last insider sell of Regencell Bioscience's stock was made by ANSCHUTZ PHILIP F on Feb 28 2018, selling 12,440,000 shares at $23.00 per share (valued at $286.12M).

Regencell Bioscience Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio

Regencell Bioscience Peer Ownership


TickerCompany
COSMCosmos Health Inc.
ANIPANI Pharmaceuticals, Inc.
ACRXTalphera, Inc.
SSICSilver Spike Investment Corp.
PAHCPhibro Animal Health Corporation
PROCProcaps Group S.A.
EGRXEagle Pharmaceuticals, Inc.
PBHPrestige Consumer Healthcare Inc.
COLLCollegium Pharmaceutical, Inc.
HEXOHEXO Corp.

RGC Ownership FAQ


Regencell Bioscience is owned by institutional shareholders (0.01%), insiders (88.76%), and public (11.23%). The largest institutional shareholder of Regencell Bioscience is UBS GROUP AG (0.01% of total shares) and the top mutual fund owner is Gabelli Gold Fund, Inc. (4.75% of total shares).

Regencell Bioscience's major institutional shareholders are UBS GROUP AG, BLACKROCK INC., and QUBE RESEARCH & TECHNOLOGIES LTD. The top five shareholders own together 0.01% of the company's share outstanding.

As of Mar 2024, there are 3 institutional shareholders of Regencell Bioscience.

UBS GROUP AG owns 1.4K shares of Regencell Bioscience, representing 0.01% of the company's total shares outstanding, valued at $6.3K (as of Mar 2024).

As of Mar 2024, BLACKROCK INC holds 238 shares of Regencell Bioscience (RGC), compromising 0.00% of the company, valued at $1.07K.

QUBE RESEARCH & TECHNOLOGIES LTD is the third largest holder of Regencell Bioscience. The company owns 13 of the company's shares outstanding (worth $64).